Combining phased and linear arrays on a single head, the Clarius PAL HD3 ultrasound device was unveiled at the recent American College of Emergency Physicians (ACEP) Scientific Assembly conference.
Featuring the imaging processing technology of traditional ultrasound systems, the newly launched Clarius PAL HD3 handheld ultrasound device reportedly offers an array of features to facilitate real-time, whole-body imaging at a patient’s bedside.
Showcased at the recent American College of Emergency Physicians (ACEP) Scientific Assembly in Philadelphia, the FDA-cleared ultrasound device provides high-resolution images from superficial anatomy down to 40 cm of depth, according to Clarius.
The company said other key features of the Clarius PAL HD3 device include advanced eight beamformer image processing technology (in comparison to one or two beamformer processing for the majority of other handheld ultrasound devices), and easy access to phased and linear arrays on a single head.
"The Clarius PAL is a big breakthrough for Clarius and for clinical ultrasound in general. Integrating the phased and linear array means you only need one transducer for 95 to 99% of the studies at the bedside," said Tom Cook, M.D., an emergency physician, and ultrasound educator who practices in Columbia, South Carolina.
FDA Clears Ultrasound AI Detection for Pleural Effusion and Consolidation
June 18th 2025The 14th FDA-cleared AI software embedded in the Exo Iris ultrasound device reportedly enables automated detection of key pulmonary findings that may facilitate detection of pneumonia and tuberculosis in seconds.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
Ultrasound-Guided Thermal Ablation Shows Low Recurrence of Thyroid Carcinoma at Five Years
June 16th 2025In a meta-analysis involving over 2,200 patients with T1NoMo papillary thyroid carcinoma, researchers noted 2 percent recurrence and no cases of lymph node metastasis five years after ultrasound-guided thermal ablation.
How to Successfully Launch a CCTA Program at Your Hospital or Practice
June 11th 2025Emphasizing increasing recognition of the capability of coronary computed tomography angiography (CCTA) for the evaluation of acute and stable chest pain, this author defuses common misperceptions and reviews key considerations for implementation of a CCTA program.